177 related articles for article (PubMed ID: 22766968)
1. Herpes zoster among persons living with HIV in the current antiretroviral therapy era.
Blank LJ; Polydefkis MJ; Moore RD; Gebo KA
J Acquir Immune Defic Syndr; 2012 Oct; 61(2):203-7. PubMed ID: 22766968
[TBL] [Abstract][Full Text] [Related]
2. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
Gebo KA; Kalyani R; Moore RD; Polydefkis MJ
J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734
[TBL] [Abstract][Full Text] [Related]
3. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC
Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.
Jansen K; Haastert B; Michalik C; Guignard A; Esser S; Dupke S; Plettenberg A; Skaletz-Rorowski A; Brockmeyer NH
BMC Infect Dis; 2013 Aug; 13():372. PubMed ID: 23937603
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.
Shearer K; Maskew M; Ajayi T; Berhanu R; Majuba P; Sanne I; Fox MP
Int J Infect Dis; 2014 Jun; 23():56-62. PubMed ID: 24680820
[TBL] [Abstract][Full Text] [Related]
8. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
Moanna A; Rimland D
Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
[TBL] [Abstract][Full Text] [Related]
9. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
Tovar Salazar A; McKhann A; Chen H; Bosch RJ; Weinberg A
AIDS Res Hum Retroviruses; 2019 Oct; 35(10):890-895. PubMed ID: 31179712
[TBL] [Abstract][Full Text] [Related]
10. Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.
Kawai K; Hawkins CA; Hertzmark E; Francis JM; Sando D; Muya AN; Ulenga N; Fawzi WW
Am J Trop Med Hyg; 2018 Feb; 98(2):396-401. PubMed ID: 29313475
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster associated with stroke incidence in people living with human immunodeficiency virus: a nested case-control study.
Ku HC; Wu YL; Yip HT; Hsieh CY; Li CY; Ou HT; Chen YC; Ko NY
BMC Infect Dis; 2023 Sep; 23(1):636. PubMed ID: 37770849
[TBL] [Abstract][Full Text] [Related]
12. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.
Levin MJ; Anderson JP; Seage GR; Williams PL;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):182-91. PubMed ID: 19131890
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Herpes Zoster in HIV-Infected Patients Undergoing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
Ku HC; Tsai YT; Konara-Mudiyanselage SP; Wu YL; Yu T; Ko NY
J Clin Med; 2021 May; 10(11):. PubMed ID: 34070645
[TBL] [Abstract][Full Text] [Related]
14. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.
Friesen KJ; Chateau D; Falk J; Alessi-Severini S; Bugden S
BMC Infect Dis; 2017 Jan; 17(1):69. PubMed ID: 28086817
[TBL] [Abstract][Full Text] [Related]
15. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.
Yanni EA; Ferreira G; Guennec M; El Hahi Y; El Ghachi A; Haguinet F; Espie E; Bianco V
BMJ Open; 2018 Jun; 8(6):e020528. PubMed ID: 29880565
[TBL] [Abstract][Full Text] [Related]
16. Incidence of herpes zoster in patients with altered immune function.
Chen SY; Suaya JA; Li Q; Galindo CM; Misurski D; Burstin S; Levin MJ
Infection; 2014 Apr; 42(2):325-34. PubMed ID: 24214127
[TBL] [Abstract][Full Text] [Related]
17. Herpes Zoster in Persons Living with HIV-1 Infection: Viremia and Immunological Defects Are Strong Risk Factors in the Era of Combination Antiretroviral Therapy.
Erdmann NB; Prentice HA; Bansal A; Wiener HW; Burkholder G; Shrestha S; Tang J
Front Public Health; 2018; 6():70. PubMed ID: 29594092
[TBL] [Abstract][Full Text] [Related]
18. Genital Herpes Zoster as Possible Indicator of HIV Infection.
Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster among HIV-infected patients in the highly active antiretroviral therapy era: Korean HIV cohort study.
Song JY; Lee JS; Jung HW; Choi HJ; Lee JS; Eom JS; Cheong HJ; Jung MH; Kim WJ
J Acquir Immune Defic Syndr; 2010 Mar; 53(3):417-8. PubMed ID: 20190589
[No Abstract] [Full Text] [Related]
20. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
